ochratoxin a has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brackhagen, L; Cramer, B; Degen, GH; Friebel, A; Ghallab, A; González, D; Hassan, R; Hengstler, JG; Hobloss, Z; Hoehme, S; Humpf, HU; Marchan, R; Myllys, M; Seddek, AL | 1 |
| Huff, JE | 1 |
1 review(s) available for ochratoxin a and Liver Dysfunction
| Article | Year |
|---|---|
Carcinogenicity of ochratoxin A in experimental animals.
Topics: Adenofibroma; Adenoma; Adult; Aflatoxin B1; Animals; Balkan Nephropathy; Bulgaria; Carcinogenicity Tests; Carcinoma; Carcinoma, Transitional Cell; Chemical and Drug Induced Liver Injury; Cocarcinogenesis; Comorbidity; Female; Hepatectomy; Humans; Hyperplasia; Incidence; Kidney; Kidney Neoplasms; Liver Diseases; Liver Neoplasms, Experimental; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Middle Aged; Mycotoxins; Ochratoxins; Precancerous Conditions; Rats; Rats, Inbred F344; Romania; Species Specificity; Urologic Neoplasms; Yugoslavia | 1991 |
1 other study(ies) available for ochratoxin a and Liver Dysfunction
| Article | Year |
|---|---|
Inhibition of cytochrome P450 enhances the nephro- and hepatotoxicity of ochratoxin A.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Lipocalin-2; Liver Diseases; Mice; Mycotoxins | 2022 |